Sjögren’s disease (SjD) is an autoimmune disease where a person’s immune system attacks their own body, typically including the tear and saliva producing glands. Approximately 4 million Americans suffer from SjD, experiencing profound dryness, joint pain, fatigue, and have an increased risk of cancer. Nonobese diabetic (NOD) mice spontaneously develop SjD-like autoimmunity, including inflammation of the glands similar to human SjD, providing a model to define the early signals driving immune cells to attack these glands. We have found that one signal required for NOD mice to develop SjD-like autoimmunity is interleukin (IL)-27. My thesis work utilized mice deficient in IL-27 signal or receiver to define how IL-27 drives SjD-like autoimmunity in NOD mice. I found that IL-27 is a required signal for T cells (both CD4 and CD8 T cells) to attack the tear-producing glands. Specifically, IL-27 triggers CD4 T cells to become specialized in talking to B cells or to become exhausted where they lose the ability to produce some inflammatory signals. Similarly, when CD8 T cells see IL-27, they become CD8 T cells with the ability to self-renew or they become exhausted. These exhausted CD4 and CD8 T cells retain some inflammatory functions suggesting they may still contribute to gland inflammation. These studies define the role of IL-27 on T cells that attack the tear-producing glands including the effects of IL-27 in driving two distinct pathways paralleled between CD4 and CD8 T cells highlighting the potential utility of IL-27 for future diagnostics or therapeutics in SjD.